Hospira Docetaxel Injection, 120 mg/12 mL, single vial

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

docetaxel, Quantity: 10 mg/mL

Verfügbar ab:

Hospira Australia Pty Ltd

INN (Internationale Bezeichnung):

Docetaxel

Darreichungsform:

Injection

Zusammensetzung:

Excipient Ingredients: citric acid; ethanol absolute; polysorbate 80; polyethylene glycol monomethyl ether

Verabreichungsweg:

Intravenous Infusion

Einheiten im Paket:

1 x 15 mL vial

Verschreibungstyp:

(S1) This Schedule is intentionally blank

Anwendungsgebiete:

Breast cancer, Non-small cell lung cancer, Stomach cancer, Head and neck cancer, Ovarian cancer, Oesophageal cancer, Uterine cancer, Prostate cancer

Produktbesonderheiten:

Visual Identification: A clear, colourless to pale yellow solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Room temperature; Container Closure: Neither child resistant closure nor restricted flow insert

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2013-10-25